1. Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of 604 occupational origin. J Occup Med. 1992;34(7):718–721.605.
2. American Cancer Society. Cancer Facts & Figures. Special 606 Section: Rare Cancers in Adults. Cancer Facts Fig Spec Sect 607. Rare Cancers Adults. 2017:30–39.608.
3. Curran BD, Sahmoud T, Therasse P, Van MJ, Postmus PE. 609 Giaccone G. Prognostic factors in patients with pleural mesothelioma: 610 the European Organization for Research and Treatment of Cancer 611 Experience. Society. 1998;16(1):145–152.612.
4. Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ. Factors predictive of survival among 337 patients with 614 mesothelioma treated between 1984 and 1994 by the Cancer and 615 Leukemia Group B. Chest. 1998;113(3):723–731.616. https://doi.org/10.1378/chest.113.3.723617.
5. Edwards JG, Leverment JN, Spyt TJ, Waller DA, O’Byrne KJ. 618 Prognostic factors for malignant mesothelioma in Leicester: validation 619 of EORTC and CALGB scores. Thorax. 1999;54(suppl. 3):731–5.